adenosine diphosphate has been researched along with lamifiban in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carteaux, JP; Roux, S; Steiner, B | 1 |
| Carroll, RC; Kouns, WC; Lanza, F; Steiner, B; Wang, XF | 1 |
| Brosstad, F; Goggin, T; Lehne, G; Midtvedt, K; Nordal, KP | 1 |
| Goto, S; Handa, M; Ikeda, Y; Murata, M | 1 |
| Carroll, RC; Liu, F; Morris, SA; Wang, XF | 1 |
| Frojmovic, M; Labarthe, B; Legrand, C | 1 |
1 review(s) available for adenosine diphosphate and lamifiban
| Article | Year |
|---|---|
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor | 2000 |
5 other study(ies) available for adenosine diphosphate and lamifiban
| Article | Year |
|---|---|
Ro 44-9883, a new non-peptidic GPIIb-GPIIIa antagonist prevents platelet loss in a guinea pig model of extracorporeal circulation.
Topics: Acetates; Adenosine Diphosphate; Amino Acid Sequence; Animals; Extracorporeal Circulation; Guinea Pigs; Hemodynamics; Heparin; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Count; Platelet Membrane Glycoproteins; Thrombocytopenia; Tyrosine | 1993 |
Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Adenosine Diphosphate; Blood Platelets; Cytoplasmic Granules; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Lysophospholipids; Peptide Fragments; Phosphorylase a; Phosphorylation; Plasma; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Thrombasthenia; Thromboxane A2; Tyrosine; Vasoconstrictor Agents | 1997 |
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction.
Topics: Acetates; Adenosine Diphosphate; Adult; Aged; Bleeding Time; Creatinine; Female; Half-Life; Hematoma; Humans; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine | 1998 |
Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Binding Sites; Cricetinae; Cross-Linking Reagents; Dimerization; Drug Synergism; Ligands; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Serotonin; Signal Transduction; Thromboxane A2; Tyrosine | 2001 |
Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
Topics: Abciximab; Acetates; Adenosine Diphosphate; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Blood Specimen Collection; Fibrinogen; Hemorheology; Humans; Immunoglobulin Fab Fragments; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Tyrosine | 2005 |